INMB (INmune Bio) Defensive Interval Ratio


INMB INmune Bio Inc INMB
52 GF Score
Price $1.94
GF Value $1.82
Valuation Fairly Valued
! 5 Warning Signs
View Full Analysis

What is INmune Bio Defensive Interval Ratio?

INMB
52GF Score
INmune Bio Inc INMB
Defensive Interval Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is INmune Bio (INMB) Overvalued in 2026?

Based on GuruFocus' analysis, INmune Bio stock appears to be overvalued. The current stock price of $1.94 is trading 6.6% above its estimated GF Value™ of $1.82. GuruFocus considers INmune Bio to be Fairly Valued.

Key valuation signals for INMB:

  • Defensive Interval Ratio:
  • GF Value™: $1.82 vs. price of $1.94 (6.6% above fair value)
  • GF Score™: 52/100 with 5 warning signs

No single metric tells the full story. See the INMB stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

INmune Bio Business Description

Address 225 NE Mizner Boulevard, Suite 640, Boca Raton, FL, USA, 33432
INmune Bio Inc is a clinical stage biotechnology pharmaceutical company focused on developing and commercializing its product candidates to treat diseases where inflammation and immunology cause a dysfunctional immune system contributing to disease. The company's pipeline products include INKmune, XPro1595, and others. It has three product platforms; The CORDStrom product platform, The DN-TNF product platform, and The Natural Killer Cell Priming Platform.
52GF Score

Get the complete analysis for INMB

Defensive Interval Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$1.94
Price
$1.82
GF Value